Endometrial Diseases Withdrawn Phase 2 Trials for Selisistat (DB13978)

Also known as: Endometrial Disease

IndicationStatusPhase
DBCOND0062869 (Endometrial Diseases)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04184323SIRT-1 Antagonism for Endometrial ReceptivityTreatment